Lv1
48 积分 2025-09-20 加入
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (I) A Randomized Trial with PCSK9 Inhibitors
17天前
已完结
Global burden of atherosclerotic cardiovascular disease attributed to lifestyle and metabolic risks
20天前
已完结
The 2026 American College of Cardiology/American Heart Association Multisociety Guideline on the Management of Dyslipidemia: A More Precise-But More Complicated-Framework for Atherosclerotic Cardiovascular Disease Prevention and Treatment
21天前
已完结
PCSK9 inhibition and inflammation: A narrative review
21天前
已完结
Visit-to-visit cholesterol variability correlates with coronary atheroma progression and clinical outcomes
22天前
已完结
Effect of Intensive Lipid-Lowering Therapy on Coronary Plaque Stabilization Derived from Optical Coherence Tomography: a Meta-analysis and Meta-regression
22天前
已完结
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque
22天前
已完结
Management of hypertriglyceridemia
22天前
已完结
Incidence and Prognostic Impact of Heart Failure Hospitalization During Follow-Up After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction. Am J Cardiol
24天前
已完结
Management of Ischemic Heart Disease in Patients With Heart Failure: JACC: Heart Failure Position Statement
25天前
已关闭
皖公网安备34019202002308
